Angiotensin-converting enzyme insertion/deletion gene polymorphism in a Tunisian healthy and acute myocardial infarction population

Genetic Testing and Molecular Biomarkers

Volumn 14, Issue 1, 2010, Pages 85-91

  Mehri, Sounira ^a,b   Baudin, Bruno ^c   Mahjoub, Sinda ^a   Zaroui, Amira ^d   Bénéteau Burnat, Bénédicte ^c   Mechmeche, Rachid ^d   Hammami, Mohamed ^b   Arab, Saïda Ben ^a  

^a UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c HÔPITAL SAINT ANTOINE   (France)

^d LA RABTA HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GLYCINE DERIVATIVE; N [3 (2 FURYLACRYLOYL)]PHENYLALANYLGLYCYLGLYCINE; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DNA POLYMORPHISM; DYSLIPIDEMIA; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERTENSION; INDEL MUTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; TUNISIA;

AGED; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INDEL MUTATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDYL-DIPEPTIDASE A; RISK FACTORS; TUNISIA;

EID: 76949104769     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2009.0105     Document Type: Article

References (51)

1. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A (2000) ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol 20:484-492.
2. Al-Eisa A, Haider MZ, Srivastva BS (2001) Angiotensin converting enzyme gene insertion=deletion polymorphism in idiopathic nephrotic syndrome in Kuwaiti Arab children. Scand J Urol Nephrol 35:239-242.
3. Araú jo MA, Goulart LR, Cordeiro ER, et al. (2005) Genotypic interactions of renin-angiotensin system genes in myocardial infarction. Int J Cardiol 103:27-32.
4. Baudin B (2002) New aspects on angiotensin-converting enzyme: from gene to disease. Clin Chem Lab Med 40:256-265.
5. Baudin B, Bénéteau-Burnat B, Crayon B, et al. (1995) Automated kinetic assay of angiotensin-converting enzyme on Synchron CX-4. Clin Chem Enzym Comms 7:41-48.
6. Bautista LE, Ardila ME, Gamarra G, et al. (2004) Angiotensinconverting enzyme gene polymorphism and risk of myocardial infarction in Colombia. Med Sci Monit 10:CR473- CR479.
7. Bénéteau-Burnat B, Baudin B (1991) Angiotensin-converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids. Crit Rev Clin Lab Sci 28:337-356.
8. Bénéteau-Burnat B, Baudin B, Morgant G, et al. (1990) Serum angiotensin-converting enzyme in healthy and sarcoidotic children: comparison with the reference interval for adults. Clin Chem 36:344-346.
9. Cambien F, Poirier O, Lecerf L, et al. (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644.
10. Cambien F, Tiret L (2007) Genetics of cardiovascular diseases: from single mutations to the whole genome. Circulation 116:1714-1724.
11. Chuang LM, Chiu KC, Chiang FT, et al. (1997) Insertion=deletion polymorphism of the angiotensin I-converting enzyme gene in patients with hypertension, non-insulin-dependent diabetes mellitus, and coronary heart disease in Taiwan. Metabolism 46:1211-1214.
12. Colhoun HM, McKeigue PM, Davey Smith G (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361:865-872.
13. Di Pasquale P, Cannizzaro S, Scalzo S, et al. (2005) Cardiovascular effects of I=D angiotensin-converting enzyme gene polymorphism in healthy subjects. Findings after follow-up of six years. Acta Cardiol 60:427-435.
14. Falchi A, Giovannoni L, Piras IS, et al. (2005) Prevalence of genetic risk factors for coronary artery disease in Corsica island (France). Exp Mol Pathol 79:210-213.
15. Faure-Delanef L, Baudin B, Bénéteau-Burnat B, et al. (1998) Plasma concentration, kinetic constants and gene polymorphism of angiotensin I-converting enzyme in centenarians. Clin Chem 44:2083-2087.
16. Fomicheva EV, Gukova SP, Larionova-Vasina VI, et al. (2000) Gene-gene interaction in the RAS system in the predisposition to myocardial infarction in elder population of St. Petersburg (Russia). Mol Genet Metab 69:76-80.
17. He Y, Tomita Y, Kusama Y, et al. (2000) A role of angiotensinconverting enzyme gene polymorphism in left ventricular remodeling after myocardial infarction. J Nippon Med Sch 67:96-104.
18. Holmer SR, Bickebö ller H, Hengstenberg C, et al. (2003) Angiotensin converting enzyme gene polymorphism and myocardial infarction: a large association and linkage study. Int J Biochem Cell Biol 35:955-962.
19. Hooper WC, Dowling NF, Wenger NK, et al. (2002) Relationship of venous thromboembolism and myocardial infarction with the renin-angiotensin system in African-Americans. Am J Hematol 70:1-8.
20. Karaali ZE, Agachan B, Yilmaz H, et al. (2004) Angiotensinconverting enzyme I=D gene polymorphisms and effects of left ventricular hypertrophy in Turkish myocardial infarction patients. Acta Cardiol 59:493-497.
21. Keavney B, McKenzie C, Parish S, et al. (2000) Large-scale test of hypothesised associations between the angiotensin-convertingenzyme insertion=deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 5355: 434-442.
22. Keavney B, McKenzie CA, Connell JM, et al. (1998) Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum Mol Genet 7:1745-1751.
23. Kruit A, Grutters JC, Gerritsen WB, et al. (2007) ACE I=Dcorrected Z-scores to identify normal and elevated ACE activity in sarcoidosis. Respir Med 101:510-515.
24. Lanfear DE, McLeod HL (2007) Pharmacogenetics: using DNA to optimize drug therapy. Am Fam Physician 76:1179-1182.
25. Lieberman J (1975) Elevation of serum angiotensinconverting enzyme (ACE) level in sarcoidosis. Am J Med 59: 365-372.
26. Li X, Wang L, Han X (2001) Association between angiotensin system gene polymorphism and essential hypertension. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18:292-295.
27. Matsubara M, Suzuki M, Fujiwara T, et al. (2002) Angiotensinconverting enzyme I=D polymorphism and hypertension: the Ohasama study. J Hypertens 20:1121-1126.
28. Mendonça I, Freitas IA, Sousa CA, et al. (2004) Angiotensin converting enzyme gene polymorphisms and coronary risk in a Portuguese population. Rev Port Cardiol 23:1593-1601.
29. Morgan TM, Coffey CS, Krumholz HM (2003) Overestimation of genetic risks owing to small sample sizes in cardiovascular studies. Clin Genet 64:7-17.
30. Naber CK, Hü sing J, Wolfhard U, et al. (2000) Interaction of the ACE D allele and the GNB3 825T allele in myocardial infarction. Hypertension 36:986-989.
31. Pallaud C, Stranieri C, Sass C, et al. (2001) Candidate gene polymorphisms in cardiovascular disease: a comparative study of frequencies between French and an Italian population. Clin Chem Lab Med 39:146-154.
32. Raynolds MV, Bristow MR, Bush EW, et al. (1993) Angiotensinconverting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 342:1073-1075.
33. Rigat B, Hubert C, Alhenc-Gelas F, et al. (1990) An insertion= deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346.
34. Rigat B, Hubert C, Corvol P, et al. (1992) PCR detection of the insertion=deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase). Nucleic Acids Res 20:1433.
35. Saeed M, Siddiqui S, Khan A, et al. (2005) Association of ACE polymorphisms with left ventricular hypertrophy. Neuro Endocrinol Lett 26:393-396.
36. Schieffer B, Drexler H (2000) ACE gene polymorphism and coronary artery disease. A question of persuasion or statistical confusion? Arterioscler Thromb Vasc Biol 20:281-282.
37. Schut AF, Bleumink GS, Stricker BH, et al. (2004) Angiotensin converting enzyme insertion=deletion polymorphism and the risk of heart failure in hypertensive subjects. Eur Heart J 25:2143-2148.
38. Seckin D, Ilhan N, Ilhan N, et al. (2006) The relationship between ACE insertion=deletion polymorphism and coronary artery disease with or without myocardial infarction. Clin Biochem 39:50-54.
39. Sekerli E, Dimitrios K, Vaya P, et al. (2008) Angiotensin-I converting enzyme gene and I=D polymorphism distribution in the Greek population and a comparison with other European populations. J Genet 87:91-93.
40. Shanmugam V, Sell KW, Saha BK (1993) Mistyping ACE heterozygotes. PCR Methods Appl 3:120-121.
41. Singh PP, Naz I, Gilmour A, et al. (2006) Association of APOE (Hha1) and ACE (I=D) gene polymorphisms with type 2 diabetes mellitus in North West India. Diabetes Res Clin Pract 74:95-102. (Pubitemid 44810196)
42. Smaoui M, Hammami S, Chaaba R, et al. (2004) Lipids and lipoprotein (a) concentration in Tunisian type 2 diabetic patients relationship to glycaemic control and coronary heart disease. J Diabetes Complications 18:258-263.
43. Steeds RP, Wardle A, Smith PD, et al. (2001) Analysis of the postulated interaction between the angiotensin II sub-type 1 receptor gene A1166C polymorphism and the insertion: deletion polymorphism of the angiotensin converting enzyme gene on risk of myocardial infarction. Atherosclerosis 154:123-128.
44. Tiret L, Bonnardeaux A, Poirier O, et al. (1994) Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 344:910-913.
45. Tiret L, Rigat B, Visvikis S, et al. (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205.
46. Touyz RM, Schiffrin EL (2000) Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52:639-672.
47. Tsutaya S, Kitaya H, Saito Y, et al. (1997) Angiotensin converting enzyme gene polymorphism and its enzyme activity in serum in young Japanese females. Tohoku J Exp Med 182:151-155.
48. van Bockxmeer FM, Mamotte CD, Burke V, et al. (2000) Angiotensin- converting enzyme gene polymorphism and premature coronary heart disease. Clin Sci (Lond) 99:247-251.
49. Van Dijk MA, Kroon I, Kamper AM, et al. (2000) The angiotensin-converting enzyme gene polymorphism and responses to angiotensins and bradykinin in the human forearm. J Cardiovasc Pharmacol 35:484-490.
50. Visvikis-Siest S, Marteau JB (2006) Genetic variants predisposing to cardiovascular disease. Curr Opin Lipidol 17:139-151.
51. Von Depka M, Czwalinna A, Wermes C, et al. (2003) The deletion polymorphism in the angiotensin-converting enzyme gene is a moderate risk factor for venous thromboembolism. Thromb Haemost 89:847-852.